// App-Quantinova.ai

1199 : Adoption in Canada of International Risk Scoring Tool (IRST) to Predict Respiratory Syncytial Virus Hospitalisation (RSVH) in Moderate-Late Preterm Infants (32-35 weeks' gestational age [wGA])

Researchers

Presenter

  • Bosco Paes

Principal Investigators

  • Barry Rodgers-Gray

  • John R. Fullarton

  • Xavier Carbonell-Estrany

Medical Centers

  • Violicom Medical Limited Aldermaston Hampshire United Kingdom

  • McMaster University Centre, Hamilton, Ontario, Canada

  • Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

Locations

  • United Kingdom

  • United States

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Obstetrics/Gynecology

  • Genetic Disorder

Disease

  • Late-preterm birth

  • Rubinstein-taybi syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved